The state of Mississippi currently has 1 active clinical trials seeking participants for Atopic Dermatitis research studies. These trials are conducted in various cities, including Jackson, Tupelo, Hattiesburg and Flowood.
A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children and Adolescents (6 to <18 Years Old) With Moderate Atopic Dermatitis
Recruiting
The purpose of the study is to assess the efficacy and safety of ruxolitinib cream in children and adolescents (6 to \<18 Years Old) with moderate atopic dermatitis.
Gender:
ALL
Ages:
Between 6 years and 17 years
Trial Updated:
08/21/2025
Locations: University of Mississippi Medical Center, Jackson, Mississippi
Conditions: Atopic Dermatitis